011dkk
13,6 %
Date:2025-06-02Time:16:59:40Latest report:Q4-2024List:Small CapTicker:PEG
Market Cap:135 mdkkEnterprise Value:142 mdkkNet Sales:- mdkkEarnings:-24,4 mdkkEmployees:0ISIN:DK0061155009

Ratios

10-year key figure history for Pharma Equity turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Pharma Equity with index and moving average MA50 and MA200.

Stockprice:0,11
MA50:0,10
MA200:0,17
Price/MA200:-34,3 %
RSI (14):70,2
Price/MA50:7,9 %

Description

Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.

Holding Companies